ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,050,000 | -43.6% | 55,652 | -64.8% | 0.00% | -50.0% |
| Q2 2019 | $1,862,000 | +214.0% | 158,268 | +264.5% | 0.00% | +100.0% |
| Q1 2019 | $593,000 | +11.7% | 43,417 | -16.2% | 0.00% | 0.0% |
| Q4 2018 | $531,000 | -90.1% | 51,807 | -84.0% | 0.00% | -80.0% |
| Q3 2018 | $5,377,000 | +144.6% | 322,970 | +132.2% | 0.01% | +150.0% |
| Q2 2018 | $2,198,000 | -17.7% | 139,115 | -33.9% | 0.00% | 0.0% |
| Q1 2018 | $2,672,000 | +315.6% | 210,377 | +274.3% | 0.00% | +100.0% |
| Q4 2017 | $643,000 | -41.4% | 56,208 | -37.2% | 0.00% | 0.0% |
| Q3 2017 | $1,097,000 | -27.7% | 89,511 | -32.5% | 0.00% | 0.0% |
| Q2 2017 | $1,518,000 | -70.1% | 132,524 | -45.6% | 0.00% | -80.0% |
| Q1 2017 | $5,071,000 | +19.8% | 243,807 | +19.8% | 0.01% | +25.0% |
| Q4 2016 | $4,234,000 | -36.3% | 203,547 | +0.3% | 0.00% | -33.3% |
| Q3 2016 | $6,648,000 | +42.4% | 202,839 | +8.5% | 0.01% | +20.0% |
| Q2 2016 | $4,667,000 | +2.1% | 186,912 | +0.1% | 0.01% | -16.7% |
| Q1 2016 | $4,571,000 | +21.3% | 186,633 | +63.7% | 0.01% | +50.0% |
| Q4 2015 | $3,767,000 | +22.7% | 113,997 | +21.7% | 0.00% | 0.0% |
| Q3 2015 | $3,069,000 | +1.2% | 93,665 | +63.6% | 0.00% | +33.3% |
| Q2 2015 | $3,032,000 | +188.2% | 57,254 | +57.0% | 0.00% | +200.0% |
| Q1 2015 | $1,052,000 | +139.6% | 36,460 | +142.0% | 0.00% | – |
| Q4 2014 | $439,000 | +99.5% | 15,064 | -13.2% | 0.00% | – |
| Q3 2014 | $220,000 | – | 17,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |